Clinical trial

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

NCT00714090

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-05-01

PhasePHASE3

Study timeline

Study start (unknown)2008-05-01Date precision: month

Registry last updated2013-07-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Unipolar Depressionunresolved

Interventions

active venlafaxine and active rTMS-repetitive transcranial magnetic stimulator, Inomed and Alpine BiomedOTHER

active rTMS -repetitive transcranial magnetic stimulator, Inomed and Alpine Biomed and sham venlafaxineOTHER

sham rTMS- repetitive transcranial magnetic stimulator, Inomed and Alpine Biomed and active venlafaxineOTHER

Sponsors & collaborators

Club rTMS et Psychiatrielead sponsor

Ministry of Health, Francecollaborator

Wyeth is now a wholly owned subsidiary of Pfizercollaborator

Mapped research locations

ParisFrance1 MarseilleFrance1 MontpellierFrance1 LilleFrance1 RennesFrance1 NiceFrance1 DijonFrance1 Clermont-FerrandFrance1 GrenobleFrance1 RouenFrance1 BesançonFrance1 PoitiersFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00714090 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.